Geneos Wealth Management Inc. Orasure Technologies Inc Transaction History

Geneos Wealth Management Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.72 - $4.61 $544 - $922	200 Added 100.0%	400 $1,000
Q2 2022 Jul 22, 2022	SELL	$2.71 - $7.12 $8,666 - $22,769	-3,198 Reduced 94.11%	200 $0
Q1 2022 May 16, 2022	SELL	$6.62 - $9.33 $1,204 - $1,698	-182 Reduced 5.08%	3,398 $23,000
Q4 2021 Feb 09, 2022	SELL	$8.3 - $11.29 $2,490 - $3,386	-300 Reduced 7.73%	3,580 $31,000
Q3 2021 Nov 09, 2021	BUY	$9.73 - $13.38 $25,298 - $34,788	2,600 Added 203.13%	3,880 $41,000
Q4 2020 May 19, 2021	BUY	$10.35 - $15.94 $4,140 - $6,376	400 Added 45.45%	1,280 $14,000
Q3 2020 Sep 07, 2021	SELL	$10.24 - $19.58 $1,024 - $1,957	-100 Reduced 10.2%	880 $9,000
Q2 2020 Sep 07, 2021	BUY	$9.71 - $17.87 $5,631 - $10,364	580 Added 145.0%	980 $10,000
Q3 2018 Sep 07, 2021	SELL	$15.25 - $17.72 $3,431 - $3,986	-225 Reduced 36.0%	400 $6,000
Q4 2017 Sep 07, 2021	SELL	$13.44 - $22.81 $19,729 - $33,485	-1,468 Reduced 70.14%	625 $11,000
Q3 2017 Sep 07, 2021	BUY	$19.97 - $22.74 $37,803 - $43,046	1,893 Added 946.5%	2,093 $47,000
Q2 2016 Sep 07, 2021	SELL	N/A	-150 Reduced 42.86%	200 $1,000
Q1 2016 Sep 07, 2021	BUY	N/A	350	350 $2,000

202

65.5M

2.2K

5.1K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $273M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.